Home Alethia BioTherapeutics

Alethia BioTherapeutics

In operation
-
Monoclonal Antibody Therapy Developer
Basic
Enterprise Profile

Basic Information

Alethia BioTherapeutics is a biotechnology company dedicated to the discovery and development of monoclonal antibody-based therapies.
Alethia BioTherapeutics, Inc.
Montreal,Quebec,Canada
15~50 people
January 01, 2002
info@alethiabio.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Lung Cancer
Application Scenarios
Innovative Drugs Monoclonal Antibody